LU83583A1 - N(1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfamoyl benzamide,son procede de preparation et son application comme medicament - Google Patents

N(1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfamoyl benzamide,son procede de preparation et son application comme medicament Download PDF

Info

Publication number
LU83583A1
LU83583A1 LU83583A LU83583A LU83583A1 LU 83583 A1 LU83583 A1 LU 83583A1 LU 83583 A LU83583 A LU 83583A LU 83583 A LU83583 A LU 83583A LU 83583 A1 LU83583 A1 LU 83583A1
Authority
LU
Luxembourg
Prior art keywords
benzamide
methoxy
amino
allyl
methylsulfamoyl
Prior art date
Application number
LU83583A
Other languages
English (en)
French (fr)
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of LU83583A1 publication Critical patent/LU83583A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
LU83583A 1980-08-28 1981-08-26 N(1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfamoyl benzamide,son procede de preparation et son application comme medicament LU83583A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8018635A FR2489327B1 (fr) 1980-08-28 1980-08-28 N (1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfa moyl benzamide, son procede de preparation et son application comme medicament
FR8018635 1980-08-28

Publications (1)

Publication Number Publication Date
LU83583A1 true LU83583A1 (fr) 1981-12-01

Family

ID=9245444

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83583A LU83583A1 (fr) 1980-08-28 1981-08-26 N(1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfamoyl benzamide,son procede de preparation et son application comme medicament

Country Status (41)

Country Link
US (2) US4405636A (it)
EP (1) EP0047207B1 (it)
JP (1) JPS5775969A (it)
KR (1) KR840002063B1 (it)
AR (1) AR226737A1 (it)
AT (1) ATE11911T1 (it)
AU (1) AU549396B2 (it)
BE (1) BE890085A (it)
BG (1) BG36931A3 (it)
CA (1) CA1168250A (it)
CH (1) CH648299A5 (it)
CS (1) CS223895B2 (it)
DD (1) DD202011A5 (it)
DE (2) DE3133768A1 (it)
DK (1) DK157845C (it)
EG (1) EG15376A (it)
ES (1) ES8301466A1 (it)
FI (1) FI73207C (it)
FR (1) FR2489327B1 (it)
GB (1) GB2083033B (it)
GR (1) GR74560B (it)
HK (1) HK55989A (it)
HU (1) HU183555B (it)
IE (1) IE51357B1 (it)
IL (1) IL63217A (it)
IN (1) IN155495B (it)
IS (1) IS1213B6 (it)
IT (1) IT1171490B (it)
JO (1) JO1120B1 (it)
LU (1) LU83583A1 (it)
MA (1) MA19218A1 (it)
MX (1) MX6707E (it)
NO (1) NO155097C (it)
OA (1) OA06877A (it)
PH (1) PH19211A (it)
PL (1) PL135397B1 (it)
PT (1) PT73509B (it)
SU (1) SU1148559A3 (it)
YU (1) YU42581B (it)
ZA (1) ZA814575B (it)
ZW (1) ZW17581A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8317597D0 (en) * 1983-06-29 1983-08-03 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2584605B1 (fr) * 1985-07-15 1988-06-17 Ile De France Application du n-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide dans le traitement de la maladie de parkinson
US7544676B2 (en) * 2005-11-10 2009-06-09 Adolor Corporation Sulfamoyl benzamides and methods of their use
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1525M (fr) * 1961-07-25 1962-11-16 Ile De France Médicaments antiémétiques nouveaux.
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR5916M (it) * 1966-01-21 1968-05-06
US3766178A (en) * 1967-04-03 1973-10-16 Ile De France Substituted 2-arylalkyloxy benzamides
GB1364231A (en) 1968-12-23 1974-08-21 Robins Co Inc A H N-/1-substituted-3-pyrrolidinyl/benzamides and thiobenzamides
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (it) * 1973-09-25 1980-06-27 Ile De France
CH605793A5 (it) * 1974-03-05 1978-10-13 Ile De France
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
US4197243A (en) * 1975-04-02 1980-04-08 Yamanouchi Pharmaceutical Co., Ltd. N-1-Benzyl-3-pyrrolidinyl-4-dimethylamino benzamide derivatives
US4186135A (en) * 1976-08-04 1980-01-29 Societe D'etudes Scientifiques Et Industrielles De L'ile-De-France Substituted 2,3-alkylene bis (oxy) benzamides and derivatives and method of preparation
FR2438650A1 (fr) * 1978-10-11 1980-05-09 Ile De France N-(1-methyl 2-pyrrolidinyl methyl) 2,3-dimethoxy 5-methylsulfamoyl benzamide et ses derives, leurs methodes de preparation et leur application dans le traitement des troubles du bas appareil urinaire
US4210660A (en) * 1978-12-20 1980-07-01 Yamanouchi Pharmaceutical Co., Ltd. Benzamide derivatives
JPS55130957A (en) * 1979-03-30 1980-10-11 Kyowa Hakko Kogyo Co Ltd Production of benzamide derivative

Also Published As

Publication number Publication date
JO1120B1 (en) 1982-07-10
ZW17581A1 (en) 1981-10-21
FI73207C (fi) 1987-09-10
BE890085A (fr) 1982-02-26
DE3133768A1 (de) 1982-06-16
GR74560B (it) 1984-06-29
CH648299A5 (fr) 1985-03-15
GB2083033B (en) 1984-02-01
EG15376A (en) 1986-12-30
EP0047207B1 (fr) 1985-02-20
DK383081A (da) 1982-03-01
DK157845C (da) 1990-07-23
YU201081A (en) 1983-10-31
KR830006201A (ko) 1983-09-20
SU1148559A3 (ru) 1985-03-30
EP0047207A1 (fr) 1982-03-10
IE51357B1 (en) 1986-12-10
MX6707E (es) 1985-10-23
JPS5775969A (en) 1982-05-12
US4405636A (en) 1983-09-20
IT1171490B (it) 1987-06-10
GB2083033A (en) 1982-03-17
ES503805A0 (es) 1982-12-01
DK157845B (da) 1990-02-26
NO155097C (no) 1987-02-11
AU549396B2 (en) 1986-01-23
IL63217A (en) 1985-03-31
FI812506L (fi) 1982-03-01
ZA814575B (en) 1982-07-28
AR226737A1 (es) 1982-08-13
PH19211A (en) 1986-02-04
CS223895B2 (en) 1983-11-25
NO812937L (no) 1982-03-01
IE811449L (en) 1982-02-28
DD202011A5 (de) 1983-08-24
AU7464281A (en) 1982-03-04
OA06877A (fr) 1983-04-30
IS1213B6 (is) 1986-04-02
PT73509A (fr) 1981-09-01
NO155097B (no) 1986-11-03
IS2654A7 (is) 1981-09-11
IN155495B (it) 1985-02-09
MA19218A1 (fr) 1982-04-01
PL135397B1 (en) 1985-10-31
IT8149179A0 (it) 1981-08-26
CA1168250A (fr) 1984-05-29
ATE11911T1 (de) 1985-03-15
ES8301466A1 (es) 1982-12-01
PT73509B (fr) 1982-10-28
BG36931A3 (en) 1985-02-15
HK55989A (en) 1989-07-21
KR840002063B1 (ko) 1984-11-09
HU183555B (en) 1984-05-28
US4550179A (en) 1985-10-29
IL63217A0 (en) 1981-10-30
YU42581B (en) 1988-10-31
JPH0233027B2 (it) 1990-07-25
FI73207B (fi) 1987-05-29
FR2489327A1 (fr) 1982-03-05
PL232686A1 (it) 1982-03-01
DE3169052D1 (en) 1985-03-28
FR2489327B1 (fr) 1984-05-18

Similar Documents

Publication Publication Date Title
CH637927A5 (fr) Derives de 4-amino-5-alkylsulfonyl ortho-anisamides et leurs procedes de preparation.
EP0112130B1 (en) Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory carboxylic acids, their preparation and use
JP2942630B2 (ja) ロイコトリエンｂ▲下４▼アンタゴニスト
WO1992020653A1 (fr) Nouveaux derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent
CH644348A5 (fr) Amino-ethers oxydes, leur procede de preparation et medicament les contenant.
LU83423A1 (fr) Pneumatique radial pour vehicules tout-terrain
EP0114014B1 (fr) Dérivés de thiéno (2,3-b) pyrrole, leur procédé de préparation et les compositions pharmaceutiques les renfermant
KR20080081057A (ko) 진해제
LU83583A1 (fr) N(1 allyl 2 pyrrolidinyl methyl) 2 methoxy 4 amino 5 methylsulfamoyl benzamide,son procede de preparation et son application comme medicament
WO1991019714A1 (fr) Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent
WO2000071118A1 (fr) Composes inhibiteurs specifiques de la phospholipase a¿2?
CN100560568C (zh) 环酰亚胺类肽金属蛋白酶抑制剂及其应用
CH627162A5 (it)
FR2501687A1 (fr) Derives basiques de composes tricycliques et procedes pour leur preparation
FR2508457A1 (fr) Pyrrolo(2,1-b)quinazolines et pyrido(2,1-b)quinazolines substituees, leur preparation et leurs utilisations therapeutiques
CA1227197A (fr) Derives de l'amino-5 dithiole-1,2 one-3 leur preparation et les compositions medicinales qui les contiennent
FR2701261A1 (fr) Nouveaux composés glucuronides de la diosmétine, leur procédé de préparation et les compositions pharmaceutiques les renfermant.
CH671396A5 (it)
FR2547726A1 (fr) Acide 2-(4-biphenylyl)-4-hexenoique et ses derives ayant une activite anti-inflammatoire
EP0993436A1 (en) (S) 2-METHYLAMINO-2-PHENYL-$i(n)-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN
FR2646350A1 (fr) Nouveaux derives benzothiazolinoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH06345731A (ja) ２−〔２−（インドール−３−イル）エチルアミノ〕−１−フェニルエタノール誘導体
EP0500713A1 (fr) Nouveaux derives du methyl-2 propionate de 3,3,5-trimethylcyclohexanol, leur procede de preparation ainsi que compositions therapeutiques les contenant
WO1998015551A1 (fr) Derives de quinuclidine en tant qu'antagonistes des recepteurs muscariniques
LU86542A1 (fr) Nouveau benzodioxepanne,son procede de synthese et ses applications en therapeutique